Daiwa Securities Group Inc. lifted its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 10.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 91,195 shares of the company's stock after buying an additional 8,834 shares during the period. Daiwa Securities Group Inc.'s holdings in GE HealthCare Technologies were worth $7,130,000 at the end of the most recent quarter.
A number of other hedge funds have also modified their holdings of GEHC. Ashton Thomas Securities LLC bought a new stake in GE HealthCare Technologies in the 3rd quarter valued at approximately $26,000. Capital Performance Advisors LLP bought a new stake in shares of GE HealthCare Technologies in the third quarter worth $26,000. Darwin Wealth Management LLC acquired a new position in GE HealthCare Technologies during the third quarter worth $31,000. Continuum Advisory LLC grew its position in GE HealthCare Technologies by 101.8% in the third quarter. Continuum Advisory LLC now owns 333 shares of the company's stock valued at $31,000 after purchasing an additional 168 shares in the last quarter. Finally, Bank of Jackson Hole Trust acquired a new stake in GE HealthCare Technologies in the 4th quarter valued at $32,000. 82.06% of the stock is currently owned by institutional investors.
Analyst Ratings Changes
A number of equities analysts have recently commented on the stock. The Goldman Sachs Group upgraded shares of GE HealthCare Technologies from a "neutral" rating to a "buy" rating and increased their price objective for the stock from $85.00 to $100.00 in a research note on Tuesday. Jefferies Financial Group upgraded GE HealthCare Technologies from a "hold" rating to a "buy" rating and raised their price target for the company from $95.00 to $103.00 in a research note on Wednesday, January 8th. Citigroup upped their price objective on GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a "buy" rating in a research note on Thursday, February 13th. Finally, Wells Fargo & Company raised their target price on shares of GE HealthCare Technologies from $96.00 to $103.00 and gave the company an "overweight" rating in a research note on Friday, February 14th. One analyst has rated the stock with a sell rating, two have issued a hold rating, nine have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $98.75.
Check Out Our Latest Research Report on GE HealthCare Technologies
GE HealthCare Technologies Trading Up 0.3 %
GEHC stock opened at $85.59 on Wednesday. The stock has a market cap of $39.14 billion, a price-to-earnings ratio of 19.77, a price-to-earnings-growth ratio of 3.19 and a beta of 1.13. The company has a fifty day moving average price of $87.06 and a two-hundred day moving average price of $86.17. GE HealthCare Technologies Inc. has a one year low of $74.51 and a one year high of $94.80. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.04 and a quick ratio of 0.83.
GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last announced its quarterly earnings results on Thursday, February 13th. The company reported $1.45 EPS for the quarter, beating analysts' consensus estimates of $1.26 by $0.19. The business had revenue of $5.32 billion for the quarter, compared to analyst estimates of $5.33 billion. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. Equities analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.
GE HealthCare Technologies Profile
(
Free Report)
GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.
Featured Articles
Want to see what other hedge funds are holding GEHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider GE HealthCare Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and GE HealthCare Technologies wasn't on the list.
While GE HealthCare Technologies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
